2010 Annual Saturday

15 / 54

Chicago, IL - 2010 ASCO Annual Meeting: Yung-Jue Bang, PhD, addresses the Lung Cancer Press Conference about Abstract "Clinical activity of the oral ALK inhibitor, PF-02341066, in ALK positive patients with non-small cell lung cancer (NSCLC)" at the American Society of Clinical Oncology Annual Meeting on Saturday, June 5, 2010. Over 32,000 physicians, researchers and healthcare professionals from over 100 countries attended the meeting, which was held at McCormick Place and featured the latest innovations in cancer research, quality, practice and technology. Date: Saturday June 5, 2010 Photo by © ASCO/Scott Morgan 2010 Technical Questions: todd@toddbuchanan.com; ASCO Contact: photos@asco.org

$Chicago, IL - 2010 ASCO Annual Meeting: Amar J. Gajjar, MD, addresses the Novel Therapies Press Conference about Abstract “A phase I pharmacokinetic trial of sonic hedgehog (SHH) antagonist GDC-0449 in pediatric patients with recurrent or refractory medulloblastoma: A Pediatric Brain Tumor Consortium study (PBTC 25)” at the American Society of Clinical Oncology Annual Meeting on Saturday, June 5, 2010. Over 32,000 physicians, researchers and healthcare professionals from over 100 countries attended the meeting, which was held at McCormick Place and featured the latest innovations in cancer research, quality, practice and technology. Date: Saturday June 5, 2010 Photo by © ASCO/Scott Morgan 2010 Technical Questions: todd@toddbuchanan.com; ASCO Contact: photos@asco.org$